Advanced Search
Displaying assets from 1 to 30 out of 3
-
Description Inhibition of ADP‐induced platelet aggregation after oral administration for 7 days of sibrafiban (2 mg twice daily) (◆), ticlopidine (250 mg twice daily)/aspirin (80 mg twice daily)(▵), or the...
Article Title: Pharmacokinetics and pharmacodynamics of sibrafiban alone or in combination with ticlopidine and aspirin
Publication Title: British Journal of Clinical Pharmacology -
Description Inhibition of collagen‐induced platelet aggregation after oral administration for 7 days of sibrafiban (2 mg twice daily) (◆), ticlopidine (250 mg twice daily)/aspirin (80 mg twice daily)(▵), or...
Article Title: Pharmacokinetics and pharmacodynamics of sibrafiban alone or in combination with ticlopidine and aspirin
Publication Title: British Journal of Clinical Pharmacology -
Description Mean free plasma concentration‐time profiles of Ro44–3888 after oral administration of sibrafiban (2 mg twice daily) alone (◆) or in combination (●) with ticlopidine (250 mg twice daily) and...
Article Title: Pharmacokinetics and pharmacodynamics of sibrafiban alone or in combination with ticlopidine and aspirin
Publication Title: British Journal of Clinical Pharmacology